Dumon, Mae Antonette D.

HRN: 08-19-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2022
CEFUROXIME 500MG (TAB)
04/20/2022
04/26/2022
PO
500mg
BID X 7 Days
WBC: 18.8; S/p LTCS With IUD Insertion For Oligohydramnios; Overt DM-insulin Requiring (controlled)
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: